SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-025709
Filing Date
2024-05-13
Accepted
2024-05-13 16:18:07
Documents
13
Period of Report
2024-05-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K ef20029006_8k.htm   iXBRL 8-K 45955
  Complete submission text file 0001140361-24-025709.txt   181565

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA insm-20240513.xsd EX-101.SCH 3859
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20240513_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20240513_pre.xml EX-101.PRE 16040
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20029006_8k_htm.xml XML 4065
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

IRS No.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 24939321
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)